DSpace About DSpace Software
 

Repositorio Atenea de la Facultad de Ciencias, UNAM >
Colecciones Ciencias >
Medicina UNAM >
Laboratorio de Inmunoparasitología >
Artículos sobre cisticercosis y T. solium publicados por investigadores mexicanos >

Please use this identifier to cite or link to this item: http://hdl.handle.net/11154/174431

Title: Current consensus guidelines for treatment of neurocysticercosis
Authors: García, HH
Evans, CAW
Nash, TE
Takayanagui, OM
White, AC
Botero, D
Rajshekhar, V
Tsang, VCW
Schantz, PM
Allan, JC
Flisser, A
Correa, D
Sarti, E
Friedland, JS
Martinez, SM
González, AE
Gilman, RH
Del Brutto, OH
Issue Date: 2002
Publisher: Clinical Microbiology Reviews
Citation: García, HH; Evans, CAW; Nash, TE; Takayanagui, OM; White, AC; Botero, D; Rajshekhar, V; Tsang, VCW; Schantz, PM; Allan, JC; Flisser, A; Correa, D; Sarti, E; Friedland, JS; Martinez, SM; González, AE; Gilman, RH; Del Brutto, OH. (2002). Current consensus guidelines for treatment of neurocysticercosis. Clinical Microbiology Review, 15(4), 747.
Abstract: Taenia solium neurocysticercosis is a common cause of epileptic seizures and other neurological morbidity in most developing countries. It is also an increasingly common diagnosis in industrialized countries because of immigration from areas where it is endemic. Its clinical manifestations are highly variable and depend on the number, stage, and size of the lesions and the host's immune response. In pan due to this variability, major discrepancies exist in the treatment of neurocysticercosis. A panel of experts in taeniasis/cysticercosis discussed the evidence on treatment of neurocysticercosis for each clinical presentation, and we present the panel's consensus and areas of disagreement. Overall, four general recommendations were made: (i) individualize therapeutic decisions, including whether to use antiparasitic drugs, based on the number, location, and viability of the parasites within the nervous system; (ii) actively manage growing cysticerci either with antiparasitic drugs or surgical excision; (iii) prioritize the management of intracranial hypertension secondary to neurocysticercosis before considering any other form of therapy; and (iv) manage seizures as done for seizures due to other causes of secondary seizures (remote symptomatic seizures) because they are due to an organic focus that has been present for a long time.
URI: http://hdl.handle.net/11154/99853
10.1128/CMR.15.4.747-756.2002
http://hdl.handle.net/11154/174431
ISSN: 0893-8512
Appears in Collections:Artículos sobre cisticercosis y T. solium publicados por investigadores mexicanos

Files in This Item:

There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

 

Valid XHTML 1.0! DSpace Software Copyright © 2002-2010  Duraspace - Feedback